Pro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot Sells 2,784 Shares

Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 2,784 shares of Pro-Dex stock in a transaction dated Monday, March 24th. The stock was sold at an average price of $50.00, for a total value of $139,200.00. Following the completion of the sale, the director now owns 295,810 shares of the company's stock, valued at $14,790,500. The trade was a 0.93 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Pro-Dex Stock Performance

Shares of NASDAQ PDEX traded down $1.75 during midday trading on Friday, hitting $48.23. 24,983 shares of the stock traded hands, compared to its average volume of 22,220. The firm has a market capitalization of $157.28 million, a P/E ratio of 24.00 and a beta of 0.68. Pro-Dex, Inc. has a one year low of $16.84 and a one year high of $59.60. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.44 and a current ratio of 2.58. The firm has a 50-day moving average of $40.21 and a two-hundred day moving average of $39.90.

Pro-Dex (NASDAQ:PDEX - Get Free Report) last posted its earnings results on Thursday, January 30th. The medical instruments supplier reported $0.61 earnings per share for the quarter, beating analysts' consensus estimates of $0.38 by $0.23. Pro-Dex had a return on equity of 21.68% and a net margin of 11.06%. On average, equities analysts forecast that Pro-Dex, Inc. will post 2 EPS for the current fiscal year.

Remove Ads

Wall Street Analysts Forecast Growth

Separately, StockNews.com lowered shares of Pro-Dex from a "buy" rating to a "hold" rating in a research note on Wednesday, March 12th.

Hedge Funds Weigh In On Pro-Dex

Institutional investors and hedge funds have recently made changes to their positions in the business. EAM Investors LLC bought a new position in Pro-Dex in the fourth quarter worth approximately $1,047,000. O Shaughnessy Asset Management LLC purchased a new stake in shares of Pro-Dex in the 4th quarter worth $995,000. 683 Capital Management LLC bought a new position in Pro-Dex in the 4th quarter worth $739,000. Ritholtz Wealth Management purchased a new position in Pro-Dex during the fourth quarter valued at $572,000. Finally, American Century Companies Inc. bought a new stake in Pro-Dex during the fourth quarter valued at about $558,000. Hedge funds and other institutional investors own 15.28% of the company's stock.

Pro-Dex Company Profile

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.